SMAD2 Gene Thoracic Aortic Aneurysm Dissection Genetic Test
At DNA Labs UAE, we offer the SMAD2 gene thoracic aortic aneurysm dissection genetic test. This test is designed to identify any mutations or variations in the SMAD2 gene that may be associated with thoracic aortic aneurysm and dissection (TAAD).
Test Components and Price
The test is priced at 4400.0 AED. The sample condition required for the test includes blood, extracted DNA, or one drop of blood on an FTA card.
Report Delivery
The test results will be delivered within 3 to 4 weeks after the sample is received.
Method
The SMAD2 gene thoracic aortic aneurysm dissection genetic test utilizes NGS (Next-Generation Sequencing) technology.
Test Type
The test falls under the category of cardiovascular pneumology disorders.
Doctor and Test Department
The test will be conducted by a cardiologist and the test department responsible for conducting the test is Genetics.
Pre Test Information
Prior to undergoing the SMAD2 gene thoracic aortic aneurysm dissection genetic test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by the condition.
Test Details
The SMAD2 gene is associated with thoracic aortic aneurysm and dissection (TAAD), a condition characterized by the weakening and tearing of the aortic wall in the chest region. The NGS genetic testing technique allows for the analysis of multiple genes simultaneously to identify any mutations or variations that may be contributing to the development of TAAD.
NGS genetic testing for TAAD can provide valuable information for diagnosis, risk assessment, and treatment decisions. It is important to note that this test is typically recommended for individuals with a personal or family history of the condition, as well as those who have other risk factors or clinical features suggestive of the disease.
It is crucial to have genetic testing performed and interpreted by healthcare professionals with expertise in genetics and genetic counseling.
| Test Name | SMAD2 Gene Thoracic aortic aneurysm dissection Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Cardiovascular Pneumology Disorders |
| Doctor | Cardiologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for SMAD2 Gene Thoracic aortic aneurysm dissection NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SMAD2 Gene Thoracic aortic aneurysm dissection NGS Genetic DNA Test gene SMAD2 |
| Test Details | The SMAD2 gene is associated with thoracic aortic aneurysm and dissection (TAAD), which is a condition characterized by the weakening and subsequent tearing of the aortic wall in the chest region. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously to identify any mutations or variations that may be associated with a particular condition. In the context of TAAD, NGS genetic testing can help identify any mutations or variations in the SMAD2 gene that may be contributing to the development of the condition. This information can be useful for diagnosis, risk assessment, and potentially guiding treatment decisions. It is important to note that genetic testing for TAAD is typically recommended for individuals with a personal or family history of the condition, as well as those who have other risk factors or clinical features suggestive of the disease. Genetic testing should be performed and interpreted by healthcare professionals with expertise in genetics and genetic counseling. |
